Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.19 | 0.6 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |